In medical practice, physicians are often faced with tough ethical and moral dilemmas, one such example is the reoccurring conflict between a patient’s hope and the truth. This paper explores two ethical dilemmas centered on compassion and the reduction of suffering: truth-telling with terminal patients and the clinical use of placebos. In each case the disclosure of truthful information could interfere with hope and suffering relief.
EliottJA.Hope-lore and the compassionate clinician. J Pain Symptom Manage2013;
45: 628–634.
2.
BegleyABlackwoodB.Truth-telling versus hope: a dilemma in practice. Int J Nurs Pract2000;
6: 26–31.
3.
ShahidiJ.Not telling the truth: Circumstances leading to concealment of diagnosis and prognosis from cancer patients. Eur J Cancer Care2010;
19: 589–593.
4.
SarafisPTsounisAMalliarouM, et al.
Disclosing the truth: a dilemma between instilling hope and respecting patient autonomy in everyday clinical practice. Glob J Health Sci2013;
6: 128–137.
5.
GillonR.Telling the truth and medical ethics. Br Med J1985;
291: 1556–1557.
6.
OlverIN.Bioethical implications of hope. In:EliottJA (ed.) Interdisciplinary Perspectives on Hope.
Hauppauge, New York:
Nova Science Publishers, Inc., 2005, pp.241–256.
7.
HassnAMHassanA.Do we always need to tell patients the truth?Lancet1998;
352: 1153.
8.
BerendesDKeefeFJSomersTJ, et al.
Hope in the context of lung cancer: relationships of hope to symptoms and psychological distress. J Pain Symptom Manage2010;
40: 174–182.
9.
FelderBE.Hope and coping in patients with cancer diagnoses. Cancer Nurs2004;
27: 320–324.
De ZuluetaP.Truth, trust and the doctor-patient relationship. In:BowmanDSpicerJ (eds) Primary Care Ethics.
Oxon, UK:
Radcliffe Publishing, 2007, pp.1–24.
17.
SpiroH.The Power of Hope: A Doctor’s Perspective.
New Haven, Connecticut:
Yale University Press, 1998.
18.
MeredithCSymondsPWebsterL, et al.
Information needs of cancer patients in west Scotland: cross sectional survey of patients’ views. BMJ1996;
313: 724–726.
19.
HeylandDKDodekPRockerG, et al.
What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ2006;
174: 627–633.
20.
NovackDHPlumerRSmithRL, et al.
Changes in physicians’ attitudes towards telling the cancer patient. JAMA1979;
241: 897–900.
21.
SimpsonC.When hope makes us vulnerable: a discussion of patient-healthcare provider interactions in the context of hope. Bioethics2004;
18: 428–447.
22.
CampbellCS.Suffering, compassion, and dignity in dying. Duq L Rev1996;
35: 109–124.
23.
ChochinovHMHackTHassardT, et al.
Dignity in the terminally ill: a cross-sectional, cohort study. Lancet2002;
360: 2026–2030.
24.
LownB.The Lost Art of Healing: Practicing Compassion in Medicine.
New York, New York:
Ballantine Books, 1999.
25.
ShapiroAKShapiroE.The placebo effect: is it much ado about nothing? In:HarringtonA (ed.) The Placebo Effect: Interdisciplinary Exploration.
Cambridge, Massachusetts:
Harvard University Press, 1999, pp.12–36.
26.
ThompsonWG.The Placebo Effect and Health: Combining Science & Compassionate Care.
Amherst, New York:
Prometheus Books, 2005.
27.
GrollD.What you don’t know can help you: the ethics of placebo treatment. J Appl Philos2011;
28: 188–202.
28.
KirschISapirsteinG.Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prev Treat1998;
1: 303–320.
29.
EcclesR.The powerful placebo in cough studies?Pulm Pharmacol Ther2002;
15: 303–308.
30.
PatelSMStasonWBLegedzaA, et al.
The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil2005;
17: 332–340.
31.
HashishIHaiHKHarveyW, et al.
Reduction of postoperative pain and swelling by ultrasound treatment: a placebo effect. Pain1998;
33: 303–311.
32.
CobbLAThomasGIDillardDH, et al.
An evaluation of internal-mammary-artery ligation by a double-blind technique. N Engl J Med1959 May 28;
260: 1115–1118.
33.
FrostFAJessenBSiggaard-AndersenJ.A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain. Lancet1980;
1: 499–500.
34.
BostickNASadeRLevineMA, et al.
Placebo use in clinical practice: report of the American medical association council on ethical and judicial affairs. J Clin Ethics2008;
19: 58–61.
TrogenBCaplanAKlassP.The ethics of open-label placebos in pediatrics. Pediatrics2017;
140: e20164328.
37.
LocherCFrey NascimentoAKirschI, et al.
Is the rationale more important than deception? a randomized control trial of open-label placebo analgesia. Pain2017;
158: 2320–2328.
38.
CarvalhoCCaetanoJMCunhaL, et al.
Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain2016;
157: 2766–2772.
39.
KaptchukTJFriedlanderEKelleyJM, et al.
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One2010;
5: e15591.
40.
KelleyJMKaptchukTJCusinC, et al.
Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom2012;
81: 312–314.
41.
HullSCCollocaLAvinsA, et al.
Patients’ attitudes about the use of placebo treatments: telephone survey. BMJ2013;
347: 1–9.
42.
BenedettiF.Placebo and the new physiology of the doctor-patient relationship. Physiol Rev2013;
93: 1207–1246.
43.
OwensDMNelsonDKTalleyNJ.The irritable bowel syndrome: Long-term prognosis and the physician-patient interaction. Ann Intern Med1995;
122: 107–112.
AmanzioMPolloAMaggiG, et al.
Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain2001;
90: 205–215.
46.
ThomasKB.General practice consultations: is there any point in being positive?Br Med J1987;
294: 1200–1202.
47.
EgbertLDBattitGEWelchCE, et al.
Reduction of postoperative pain by encouragement and instruction of patients – a study of doctor-patient rapport. N Engl J Med1964;
270: 825–827.
